Full name
STUDIO URBIPLAN SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.23.Z - Dental practice
47.74.Z - Retail sale of medical and orthopedic products
71.11.Z - Architectural activities
71.12.B - Engineering activities and related technical consultancy
74.14.Z - Other specialized design activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.91.A - Diagnostic imaging activities
86.95.Z - Physiotherapy activities
86.99.D - Other healthcare services
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,1 | 0,1 | 0,1 | 30,4 |
Gross profit (loss) | 0,1 | 0,1 | 0,1 | 27,6 |
EBITDA | 0,1 | 0,2 | 0,4 | 64 |
Short time liabilities | 0 | 0 | 0,1 | 1226,4 |
Other operating costs | 0 | 0 | 0 | 243,2 |
Equity capital | 0,2 | 0,3 | 0,4 | 32,3 |
Operating profit (EBIT) | 0,1 | 0,1 | 0,1 | 28,7 |
Assets | 0,3 | 0,3 | 0,6 | 67,3 |
Net profit (loss) | 0,1 | 0,1 | 0,1 | 27,3 |
Cash | 0,2 | 0,2 | 0,2 | -2,2 |
Liabilities and provisions for liabilities | 0 | 0 | 0,1 | 1226,4 |
Net income from sale | 0,9 | 1,3 | 2,1 | 57,7 |
Working assets | 0,2 | 0,3 | 0,2 | -22,6 |
Other income costs | 0 | 0 | 0 | -45,5 |
Depreciation | 0 | 0,1 | 0,2 | 91,6 |
% | % | % | p.p. | |
Profitability of capital | 35,5 | 25,4 | 24,4 | -1 |
Equity capital to total assets | 92,4 | 97,1 | 76,8 | -20,3 |
Gross profit margin | 11,5 | 7 | 5,7 | -1,3 |
EBITDA Margin | 15,8 | 16 | 16,6 | 0,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 9 | 3 | 23 | 20 |
Current financial liquidity indicator | 11.006570816040039 | 30.75638198852539 | 1.7946745157241821 | -29 |
Net dept to EBITDA | -1.1300363540649414 | -1.0290547609329224 | -0.2582155168056488 | 0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane